Next Article in Journal
Effect of Food Matrix and Treatment Time on the Effectiveness of Grape Seed Extract as an Antilisterial Treatment in Fresh Produce
Previous Article in Journal
Chemical Constituents, Antioxidant Potential, and Antimicrobial Efficacy of Pimpinella anisum Extracts against Multidrug-Resistant Bacteria
Previous Article in Special Issue
Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue: “Parasitic Infection and Host Immunity”: Editorial

by
Debora Decote-Ricardo
1,
Danielle de Oliveira Nascimento
1,
Leonardo Freire-de-Lima
2,
Alexandre Morrot
3,4,* and
Celio Geraldo Freire-de-Lima
2,*
1
Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro, Rio de Janeiro 23890-000, Brazil
2
Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-170, Brazil
3
Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21044-020, Brazil
4
Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil
*
Authors to whom correspondence should be addressed.
Microorganisms 2023, 11(4), 1027; https://doi.org/10.3390/microorganisms11041027
Submission received: 10 March 2023 / Revised: 23 March 2023 / Accepted: 3 April 2023 / Published: 14 April 2023
(This article belongs to the Special Issue Parasitic Infection and Host Immunity)
Parasite–host interactions depend on a complex interplay between the metabolism of the parasite, their antigens, and the host immune response system [1,2]. In this Special Issue, we present various contributions on this topic, reporting extremely relevant issues in the interaction of different parasites with the host immunity.
One of these issues is the resistance to antimalarial treatments, which is already well documented for infection with P. vivax [3,4,5,6,7,8]. However, the molecular markers involved in the development of this resistance are not yet characterized [9]. The increase in pfmrps1 expression, a multidrug resistance-associated protein, is associated with antimalarial resistance. Polymorphisms in this gene are related to in vivo selection after treatment [10]. Interestingly, Yin et al. [4] show an association between pvmrp1 and the development of P. vivax resistance to antimalarial drugs. They found some unreported point mutations of pvmrp1, from collected samples, and S354N substitution which may lead to resistance to chloroquine in P. vivax. An analysis of the 29 polymorphisms of pvmrp1 within the 166 global isolates has revealed low nucleotide diversity and high haplotype diversity under purifying selection. However, analyzing the correlation between sensitivity/insensitivity to chloroquine and mutations has not showed any association between an increase in the number of copies of pvmep1 and its susceptibility to antimalarial drugs.
Relevant to the topic, Goo, Y. K. et al. [11] made a valuable contribution by discussing the biological and pathophysiological aspects of malaria caused by P. vivax from the perspective of the subtelomeric vir multigene superfamily. In P. falciparum, the var gene family encoding PfEMP1 protein plays a key role in antigenic variation and cytoadherence [12]. The similar vir multigene from P. vivax has been studied as an important superfamily gene that takes part in the pathogenesis of vivax malaria besides triggering the host immune activation [13]. Approximately 50% of the population infected by P. vivax have antibodies against the VIR protein, but the cellular response to this protein is not equally efficient. The number of studies on naturally acquired immune-response-induced VIR proteins in field populations from vivax malaria-endemic areas has been limited. Thus far, several studies have demonstrated the capacity of VIR proteins for mediating cytoadherence and immune response activation.
In addition, Martins et al. [14] have evaluated the role of SIRPα receptors in Plasmodium-induced immunosuppression. This receptor is recognized as mediating the inhibitory signals of innate immunity functions [15,16,17]. Thus, the group investigated the modulatory effects of Plasmodium crude extracts for SIRPα expression from innate immune cells. They incubated PBMC from healthy individuals in the presence of crude extracts obtained from both P. falciparum and P. vivax, using LPS as a control stimulus. The authors have observed that crude extracts derived from both parasites can induce increased SIRPα expression in monocytes, but not in dendritic cells. The authors pointed out that a study with malaria patients from the Brazilian Amazon region is currently in progress.
Another contribution in this field focused on important aspects of the disease caused by infection with freshwater parasitic worms from certain tropical and subtropical countries, such as schistosomiasis. One of the key characteristics of Schistossoma mansoni infection is the eosinophilia accompanied by the granuloma formation, resulting from the migration of inflammatory cells to the site of infection during the control of infection [18,19]. Malta et al. [20] reviewed important aspects of the immunopathology of S. mansoni infection from that perspective, taking into account relevant aspects such as the host’s immune response, the architecture of the granuloma, the recruitment and accumulation of eosinophils, the mechanisms of action of these cells, as well as their interaction with other cells using different animal models of infection. Although the primary functions of eosinophils in S. mansoni infection are still unclear, the authors stated that eosinophil cells play an important role in granuloma formation and the protection of parenchymal tissue, as they are critical for the destruction of entrapped eggs needed for the remodeling and repair of infected tissues.
In another contribution, Saïdi et al. [21] developed a direct immunofluorescence (DIF) technique that, instead of identifying Leishmania amastigotes, marks the presence of scattered antigens, as well as their degraded residues and soluble components, via the cytoplasm and plasma membrane of host cells. The need for new and more accurate methods for the diagnosis of cutaneous leishmaniasis is necessary since these gold methods have a detection margin of amastigotes between 60 and 80% [22,23]. The DIF assay applied to dermal scrapings was more sensitive than microscopy and as sensitive as PCR. Furthermore, the DIF assay using anti-L. major polyclonal IgG-FITC recognized other Leishmania species present in Tunisia.
In addition, Vargas-Villavicencio et al. [24] have reported that infections with Toxoplasma gondii yield a phenomenon where IgM, usually used to detect acute infection, ends up lasting for months. The authors also referred to chronic IgM, which makes the diagnosis difficult. Although this event has not yet been clarified, in this review, the authors propose various hypotheses based on original studies. In fact, there is evidence that gestational sexual hormones can prolong the acute infection. Thus, the reactivation of T. gondii could continuously induce low sustained IgM levels for long periods, as well as B-1 cell-derived natural antibodies and Ig class switch alterations caused by the parasite or cytokines taken from inflammatory host responses.
As presented in this Special Issue, these works highlight the complexity in this vast and intriguing field of research. Using different parasite infection models, in this Special Issue, the authors showed that host–pathogen interactions are specific for each pathogen, thus raising different challenges for the study of pathogenesis mechanisms, infection control, as well as the treatment and diagnostic methods of human parasitic diseases.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Moreira, D.; Estaquier, J.; Cordeiro-da-Silva, A.; Silvestre, R. Metabolic Crosstalk Between Host and Parasitic Pathogens. Exp. Suppl. 2018, 109, 421–458. [Google Scholar] [CrossRef] [PubMed]
  2. Harnett, W. Secretory products of helminth parasites as immunomodulators. Mol. Biochem. Parasitol. 2014, 195, 130–136. [Google Scholar] [CrossRef] [PubMed]
  3. Xu, S.; Zeng, W.; Ngassa Mbenda, H.G.; Liu, H.; Chen, X.; Xiang, Z.; Li, C.; Zhang, Y.; Baird, J.K.; Yang, Z.; et al. Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial. Travel Med. Infect. Dis. 2020, 36, 101499. [Google Scholar] [CrossRef]
  4. Yin, Y.; Chen, G.; Nyunt, M.H.; Zhang, M.; Liu, Y.; Zhu, G.; He, X.; Tian, F.; Cao, J.; Han, E.T.; et al. Prevalence of pvmrp1 Polymorphisms and Its Contribution to Antimalarial Response. Microorganisms 2022, 10, 1482. [Google Scholar] [CrossRef]
  5. Htun, M.W.; Mon, N.C.N.; Aye, K.M.; Hlaing, C.M.; Kyaw, M.P.; Handayuni, I.; Trimarsanto, H.; Bustos, D.; Ringwald, P.; Price, R.N.; et al. Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow. Malar. J. 2017, 16, 281. [Google Scholar] [CrossRef] [PubMed]
  6. Yuan, L.; Wang, Y.; Parker, D.M.; Gupta, B.; Yang, Z.; Liu, H.; Fan, Q.; Cao, Y.; Xiao, Y.; Lee, M.C.; et al. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar. Antimicrob. Agents Chemother. 2015, 59, 1230–1235. [Google Scholar] [CrossRef] [Green Version]
  7. Ngassa Mbenda, H.G.; Wang, M.; Guo, J.; Siddiqui, F.A.; Hu, Y.; Yang, Z.; Kittichai, V.; Sattabongkot, J.; Cao, Y.; Jiang, L.; et al. Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination. Parasit. Vectors 2020, 13, 67. [Google Scholar] [CrossRef] [Green Version]
  8. Diez Benavente, E.; Ward, Z.; Chan, W.; Mohareb, F.R.; Sutherland, C.J.; Roper, C.; Campino, S.; Clark, T.G. Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure. PLoS ONE 2017, 12, e0177134. [Google Scholar] [CrossRef] [Green Version]
  9. Benavente, E.D.; Manko, E.; Phelan, J.; Campos, M.; Nolder, D.; Fernandez, D.; Velez-Tobon, G.; Castano, A.T.; Dombrowski, J.G.; Marinho, C.R.F.; et al. Distinctive genetic structure and selection patterns in Plasmodium vivax from South Asia and East Africa. Nat. Commun. 2021, 12, 3160. [Google Scholar] [CrossRef]
  10. Valderramos, S.G.; Fidock, D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 2006, 27, 594–601. [Google Scholar] [CrossRef] [Green Version]
  11. Goo, Y.K. Vivax Malaria and the Potential Role of the Subtelomeric Multigene vir Superfamily. Microorganisms 2022, 10, 1083. [Google Scholar] [CrossRef] [PubMed]
  12. Smith, J.D.; Gamain, B.; Baruch, D.I.; Kyes, S. Decoding the language of var genes and Plasmodium falciparum sequestration. Trends Parasitol. 2001, 17, 538–545. [Google Scholar] [CrossRef] [PubMed]
  13. Schappo, A.P.; Bittencourt, N.C.; Bertolla, L.P.; Forcellini, S.; da Silva, A.B.I.E.; Dos Santos, H.G.; Gervásio, J.H.; Lacerda, M.V.; Lopes, S.C.; Costa, F.T.; et al. Antigenicity and adhesiveness of a Plasmodium vivax VIR-E protein from Brazilian isolates. Mem. Inst. Oswaldo Cruz 2022, 116, e210227. [Google Scholar] [CrossRef] [PubMed]
  14. Martins, P.D.C.; de Souza, H.; Blanco, C.M.; Santos-de-Oliveira, L.; Pratt-Riccio, L.R.; Daniel-Ribeiro, C.T.; Totino, P.R.R. Modulation of Signal Regulatory Protein alpha (SIRPalpha) by Plasmodium Antigenic Extract: A Preliminary In Vitro Study on Peripheral Blood Mononuclear Cells. Microorganisms 2022, 10, 903. [Google Scholar] [CrossRef] [PubMed]
  15. Gardai, S.J.; Xiao, Y.Q.; Dickinson, M.; Nick, J.A.; Voelker, D.R.; Greene, K.E.; Henson, P.M. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003, 115, 13–23. [Google Scholar] [CrossRef] [Green Version]
  16. Janssen, W.J.; McPhillips, K.A.; Dickinson, M.G.; Linderman, D.J.; Morimoto, K.; Xiao, Y.Q.; Oldham, K.M.; Vandivier, R.W.; Henson, P.M.; Gardai, S.J. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am. J. Respir. Crit. Care Med. 2008, 178, 158–167. [Google Scholar] [CrossRef] [Green Version]
  17. Latour, S.; Tanaka, H.; Demeure, C.; Mateo, V.; Rubio, M.; Brown, E.J.; Maliszewski, C.; Lindberg, F.P.; Oldenborg, A.; Ullrich, A.; et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: Down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J. Immunol. 2001, 167, 2547–2554. [Google Scholar] [CrossRef] [Green Version]
  18. Butterworth, A.E. Immunological aspects of human schistosomiasis. Br. Med. Bull. 1998, 54, 357–368. [Google Scholar] [CrossRef] [Green Version]
  19. Ariyaratne, A.; Finney, C.A.M. Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space. Infect. Immun. 2019, 87, e00127-19. [Google Scholar] [CrossRef] [Green Version]
  20. Malta, K.K.; Palazzi, C.; Neves, V.H.; Aguiar, Y.; Silva, T.P.; Melo, R.C.N. Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context. Microorganisms 2022, 10, 2022. [Google Scholar] [CrossRef]
  21. Saidi, N.; Galai, Y.; Ben-Abid, M.; Boussoffara, T.; Ben-Sghaier, I.; Aoun, K.; Bouratbine, A. Imaging Leishmania major Antigens in Experimentally Infected Macrophages and Dermal Scrapings from Cutaneous Leishmaniasis Lesions in Tunisia. Microorganisms 2022, 10, 1157. [Google Scholar] [CrossRef] [PubMed]
  22. Beniklef, R.; Aoun, K.; Boudrissa, K.; Ben Abid, M.; Cherif, K.; Aissi, W.; Benrekta, S.; Boubidi, S.C.; Spath, G.F.; Bouratbine, A.; et al. Cutaneous Leishmaniasis in Algeria; Highlight on the Focus of M’Sila. Microorganisms 2021, 9, 962. [Google Scholar] [CrossRef] [PubMed]
  23. Aoun, K.; Tebrouri, M.; Ben Abdallah, R.; Bellali, H.; Souissi, O.; Bouratbine, A. [Contribution of Real-Time PCR in the Diagnosis of Cutaneous Leishmaniasis: Experience of the Pasteur Institute of Tunis]. Bull. Soc. Pathol. Exot. 2020, 113, 251–253. [Google Scholar] [CrossRef] [PubMed]
  24. Vargas-Villavicencio, J.A.; Canedo-Solares, I.; Correa, D. Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms? Microorganisms 2022, 10, 1659. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Decote-Ricardo, D.; de Oliveira Nascimento, D.; Freire-de-Lima, L.; Morrot, A.; Freire-de-Lima, C.G. Special Issue: “Parasitic Infection and Host Immunity”: Editorial. Microorganisms 2023, 11, 1027. https://doi.org/10.3390/microorganisms11041027

AMA Style

Decote-Ricardo D, de Oliveira Nascimento D, Freire-de-Lima L, Morrot A, Freire-de-Lima CG. Special Issue: “Parasitic Infection and Host Immunity”: Editorial. Microorganisms. 2023; 11(4):1027. https://doi.org/10.3390/microorganisms11041027

Chicago/Turabian Style

Decote-Ricardo, Debora, Danielle de Oliveira Nascimento, Leonardo Freire-de-Lima, Alexandre Morrot, and Celio Geraldo Freire-de-Lima. 2023. "Special Issue: “Parasitic Infection and Host Immunity”: Editorial" Microorganisms 11, no. 4: 1027. https://doi.org/10.3390/microorganisms11041027

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop